Trade Summary

5 days ago, Rhodes Jason P, serving as Dir at Dyne Therapeutics, Inc. (DYN), sold 504,695 shares at $21.23 per share, for a total transaction value of $10,712,549.82. Following this transaction, Rhodes Jason P now holds 975,931 shares of DYN.

This sale represents a 34.09% decrease in Rhodes Jason P's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 26, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 30, 2026 at 7:05 PM ET, 4 days after the trade was made.

Dyne Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.